Dr. Stacey Clardy talks with Dr. Elia Sechi about the importance of understanding lab test results, the performance characteristics of assays, and the real-world implications of false positives in myasthenia gravis testing.

Read the related article in Neurology®.

Disclosures can be found at Neurology.org.

Dr. Roy E. Strowd talks with Dr. Susannah Cornes about a teaching incentive initiative designed to support and reward faculty in academic neurology.

Read the related article in Neurology® Education.

Disclosures can be found at Neurology.org.

Dr. Jeff Ratliff talks with Dr. Per Borghammer about the classification of Lewy body disease into brain-first and body-first subtypes, with a focus on the newly identified parasympathetic and sympathetic subtypes within the body-first category.

Read the related article in Nature.

Disclosures can be found at Neurology.org.

Dr. Stacey Clardy talks with Dr. Janis Miyasaki about her journey into neurology, the integration of palliative care into neurologic practice, and the critical importance of patient-centered care.

Read more about the 2025 AAN President's Award.

Disclosures can be found at Neurology.org.

Dr. Jessica Ailani talks with Dr. Kathleen Digre about the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade.

Disclosures can be found at Neurology.org.

Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease.

Purchase Annual Meeting On Demand to get access to the recordings and the ability to claim CME through March 1, 2026.

Disclosures can be found at Neurology.org.

The May 2025 recall features four previously posted episodes on myasthenia gravis. The first episode has Dr. Fredrik Piehl discussing rituximab for new-onset generalized MG. In the second episode, Dr. Vera Bril explores the potential use of immunoglobulin as a corticosteroid-sparing agent in MG patients. The third episode features Dr. Ali A. Habib discussing trends in hospital admissions and in-hospital mortality for adult MG patients. The series concludes with Dr. Jennifer Morganroth addressing the increase in thymectomy procedures post-MGTX trial, disparities in access to these surgeries among different demographic groups, and the rise of minimally invasive surgical techniques.

Podcast links:

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis

Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis

Hospitalizations and Mortality from MG Hospitalizations and Mortality From Myasthenia Gravis

Trends and Disparities in the Utilization of Thymectomy for MG in the US

Article links:

Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis

Randomized Double-Blind Placebo-Controlled Trial of the Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis

Hospitalizations and Mortality From Myasthenia Gravis

Trends and Disparities in the Utilization of Thymectomy for Myasthenia Gravis in the United States

Disclosures can be found at Neurology.org.

Dr. Greg Cooper talks with Dr. Joseph Therriault about the use of plasma biomarkers in diagnosing Alzheimer disease, emphasizing the importance of interpreting these biomarkers within the clinical context of the patient.

Read the related article in Nature.

Disclosures can be found at Neurology.org.